These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Preparation of vaccines]. Ruitenberg EJ Tijdschr Diergeneeskd; 1990 Apr; 115(8):362-70. PubMed ID: 2186504 [TBL] [Abstract][Full Text] [Related]
4. [Improvement of veterinary vaccines through the use of new adjuvants]. Hilgers LA Tijdschr Diergeneeskd; 1991 May; 116(10):508-12. PubMed ID: 2048061 [TBL] [Abstract][Full Text] [Related]
5. Influenza vaccines: from whole virus preparations to recombinant protein technology. Huber VC Expert Rev Vaccines; 2014 Jan; 13(1):31-42. PubMed ID: 24192014 [TBL] [Abstract][Full Text] [Related]
6. Technologies for the design, discovery, formulation and administration of vaccines. Ellis RW Vaccine; 2001 Mar; 19(17-19):2681-7. PubMed ID: 11257409 [TBL] [Abstract][Full Text] [Related]
7. A review of the current status of enteric vaccines. Levine MM; Noriega F P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876 [TBL] [Abstract][Full Text] [Related]
8. [Antiviral vaccines]. Girard M Med Trop (Mars); 1999; 59(4 Pt 2):522-6. PubMed ID: 10901858 [TBL] [Abstract][Full Text] [Related]
9. Construction of a bivalent oral vaccine for prevention of typhoid fever and cholera diarrhea. Ma QJ; Yu XQ; Liu CX; Zhou JG; Xiong LS; Huang CF Sci China B; 1990 Jan; 33(1):44-9. PubMed ID: 2190570 [TBL] [Abstract][Full Text] [Related]
10. Fish vaccine antigens produced or delivered by recombinant DNA technologies. Leong JC; Anderson E; Bootland LM; Chiou PW; Johnson M; Kim C; Mourich D; Trobridge G Dev Biol Stand; 1997; 90():267-77. PubMed ID: 9270855 [TBL] [Abstract][Full Text] [Related]
11. [The prospects for the development of viral vaccines]. Bektimirov TA; Gorbunov MA Voen Med Zh; 1995 Jul; (7):45-8. PubMed ID: 7571512 [No Abstract] [Full Text] [Related]
12. [Old and new prescriptions for infectious diseases and the newest recipes for biomedical products in plants]. Koprowski H Arch Immunol Ther Exp (Warsz); 2002; 50(6):365-9. PubMed ID: 12549429 [TBL] [Abstract][Full Text] [Related]
14. Progress in the development of new vaccines against tuberculosis. Orme IM Int J Tuberc Lung Dis; 1997 Apr; 1(2):95-100. PubMed ID: 9441089 [TBL] [Abstract][Full Text] [Related]
15. New technologies for vaccines. Dorner F; Eibl J; Barrett PN Wien Klin Wochenschr; 1999 Mar; 111(5):199-206. PubMed ID: 10226350 [TBL] [Abstract][Full Text] [Related]
18. Innovative vaccine production technologies: the evolution and value of vaccine production technologies. Bae K; Choi J; Jang Y; Ahn S; Hur B Arch Pharm Res; 2009 Apr; 32(4):465-80. PubMed ID: 19407962 [TBL] [Abstract][Full Text] [Related]
19. Recombinant DNA technology for producing new rinderpest virus vaccines. Barrett T Expert Rev Vaccines; 2005 Feb; 4(1):113-20. PubMed ID: 15757478 [TBL] [Abstract][Full Text] [Related]
20. Eighteen years of vaccination against viral haemorrhagic septicaemia in France. de Kinkelin P; Béarzotti M; Castric J; Nougayrède P; Lecocq-Xhonneux F; Thiry M Vet Res; 1995; 26(5-6):379-87. PubMed ID: 8581010 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]